Non-thionamide antithyroid drug options in Graves' hyperthyroidism

Ruslan, Aliya and Okosieme, Onyebuchi E. 2023. Non-thionamide antithyroid drug options in Graves' hyperthyroidism. Expert Review of Endocrinology and Metabolism 18 (1) , pp. 67-79. 10.1080/17446651.2023.2167709

PDF - Accepted Post-Print Version Download (498kB)

Abstract

The thionamide anti-thyroid drugs namely carbimazole, methimazole, and propylthiouracil, have been the predominant therapy modality for Graves’ hyperthyroidism for over 60 years. Although these agents have proven efficacy and favorable side-effect profiles, non-thionamide alternatives are occasionally indicated in patients who are intolerant or unresponsive to thionamides alone. This review examines the available non-thionamide drug options for the control of Graves’ hyperthyroidism and summarizes their clinical utility, efficacy, and limitations.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Publisher:	Taylor and Francis Group
ISSN:	1744-6651
Date of First Compliant Deposit:	30 March 2023
Date of Acceptance:	9 January 2023
Last Modified:	11 Nov 2024 21:30
URI:	https://orca.cardiff.ac.uk/id/eprint/158196

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item